How is secondary hyperparathyroidism managed?

Updated: Oct 02, 2018
  • Author: Lawrence Kim, MD, FACS, FACE; Chief Editor: Romesh Khardori, MD, PhD, FACP  more...
  • Print


Unlike primary hyperparathyroidism, medical management is the mainstay of treatment for secondary hyperparathyroidism.

Correcting vitamin D deficiency can be achieved using 50,000-IU capsule of vitamin D-2 once a week for 8 weeks and repeating the course for another 8 weeks if needed to achieve vitamin D sufficiency.    

For patients with CKD, the National Kidney Foundation (NKF) published clinical practice guidelines as part of its Kidney Disease Outcomes Quality Initiative (KDOQI). In general, it has been recommended to reduce parathyroid hormone levels to within a range that supports normal bone turnover and minimizes ectopic calcification.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!